N
NVS
Novartis
158.86
+2.62+1.68%After Hours: 159.61 +0.75 +0.47%19:41 08/21 EDT
OPEN/PREV CLOSE156.17/156.24
TODAY RANGE156.10-159.72
VOL1.18M
MARKET CAP301.95B
52 WEEK RANGE118.00-165.46
AVG VOL (3M)1.89M
% TURNOVER0.06%
TURNOVER--
P/E (TTM)23.99
% RANGE2.31%
EPS(TTM)6.62
P/E(FORWARD)22.50
P/B7.27
BVPS21.86
DIVIDEND4.740
P/S5.38
BETA--
DIV YIELD2.98%
FREE FLOAT MKT CAP301.90B
SHARES OUTSTANDING1.90B
NEXT EARNINGS04/27-05/01
FREE FLOAT1.90B
LOT SIZE1
EX-DATE03/11/2026
News
Press Releases
Financial Reports
Profile
Seeking Alpha·5h ago
TG Therapeutics: Briumvi's Growth Attracts Buyout Rumors
TipRanks·19h ago
3 Stocks Under $10 With Over 100% Upside, According to Analysts
Seeking Alpha·3d ago
Trump nominates White House adviser Overton as next FDA commissioner
Seeking Alpha·3d ago
Alnylam initiated an outperform at BMO on RNAi pipeline
Seeking Alpha·3d ago
Trump expected to nominate White House aide Heidi Overton as FDA commissioner
TipRanks·3d ago
Novartis’ iptacopan granted FDA orphan designation
Seeking Alpha·4d ago
Enliven a new outperform at Barclays on potential of CML asset
TipRanks·5d ago
3 Dividend ETFs Crushing the S&P 500 in 2026
Seeking Alpha·08/13 19:24
Immunome: Maintaining My 'Strong Buy' Rating With 2 Catalysts On The Horizon
Seeking Alpha·08/13 17:26
Roche Is Getting More Benefit Of The Doubt On Improving Execution
Seeking Alpha·08/13 15:58
Pharma companies sour on Swiss drug applications amid Trump’s MFN policy
TipRanks·08/10 15:22
3 Vanguard Dividend ETFs to Boost Passive Income
NASDAQ·08/10 14:51
Noteworthy ETF Outflows: AVSD, HSBC, NVS, MUFG